Works matching IS 15228517 AND DT 2021 AND VI 23 AND IP 3

Results: 26

Highlights from the Literature.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 352, doi. 10.1093/neuonc/noab043

By:

Viapiano, Mariano;
Ghosh, Sourav;
Soffietti, Riccardo;
Abounader, Roger;
Huse, Jason

Publication type:

Article

Corrigendum.

Published in:: Neuro-Oncology, 2021, v. 23, n. 3, p. 508, doi. 10.1093/neuonc/noy171
Publication type:: Article

Corrigendum.

Published in:: Neuro-Oncology, 2021, v. 23, n. 3, p. 523, doi. 10.1093/neuonc/noy106
Publication type:: Article

Forthcoming Meetings.

Published in:: Neuro-Oncology, 2021, v. 23, n. 3, p. 524, doi. 10.1093/neuonc/noab042
Publication type:: Article

Reimagining external beam radiotherapy for glioblastoma: "old beam, new trick".

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 345, doi. 10.1093/neuonc/noab008

By:

Mathen, Peter;
Smart, DeeDee K

Publication type:

Article

Radiation therapy to the developing brain: advanced technology is ready for robust optimization parameters.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 350, doi. 10.1093/neuonc/noab007

By:

Perkins, Stephanie;
Acharya, Sahaja

Publication type:

Article

Early results from the CODEL trial for anaplastic oligodendrogliomas: is temozolomide futile?

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 347, doi. 10.1093/neuonc/noab006

By:

Lassman, Andrew B;
Cloughesy, Timothy F

Publication type:

Article

Targeting phospholipid metabolism for glioblastoma therapy.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 343, doi. 10.1093/neuonc/noaa309

By:

Huang, Tianzhi;
Cheng, Shi-Yuan

Publication type:

Article

Stemming the growth of pediatric gliomas through histone modification.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 341, doi. 10.1093/neuonc/noaa302

By:

Fults, Daniel W

Publication type:

Article

Functional connectivity within glioblastoma impacts overall survival.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 412, doi. 10.1093/neuonc/noaa189

By:

Daniel, Andy G S;
Park, Ki Yun;
Roland, Jarod L;
Dierker, Donna;
Gross, James;
Humphries, Joseph B;
Hacker, Carl D;
Snyder, Abraham Z;
Shimony, Joshua S;
Leuthardt, Eric C

Publication type:

Article

Pulsed radiation therapy for the treatment of newly diagnosed glioblastoma.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 447, doi. 10.1093/neuonc/noaa165

By:

Almahariq, Muayad F;
Quinn, Thomas J;
Arden, Jessica D;
Roskos, P T;
Wilson, George D;
Marples, Brian;
Grills, Inga S;
Chen, Peter Y;
Krauss, Daniel J;
Chinnaiyan, Prakash;
Dilworth, Joshua T

Publication type:

Article

Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 506, doi. 10.1093/neuonc/noaa305

By:

Wen, Patrick Y;
Weller, Michael;
Chiocca, Ennio Antonio;
Lim, Michael;
Tonn, Joerg-Christian;
Zadeh, Gelareh;
Aldape, Kenneth;
van den Bent, Martin

Publication type:

Article

Maximizing extent of resection while minimizing the risk of neurological morbidity in glioma patients: a novel grading scale to translate these surgical goals into a merged onco-functional clinical outcome.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 504, doi. 10.1093/neuonc/noaa288

By:

Gerritsen, Jasper Kees Wim;
Vincent, Arnaud Jean Pierre Edouard;
Vleeschouwer, Steven De

Publication type:

Article

The actinomycin D molecule docks to a hydrophilic section of the SOX2 high-mobility group (HMG) domain.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 500, doi. 10.1093/neuonc/noaa299

By:

Lehrer, Steven;
Rheinstein, Peter H

Publication type:

Article

Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 502, doi. 10.1093/neuonc/noaa287

By:

López, Antonio José Vargas

Publication type:

Article

Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 356, doi. 10.1093/neuonc/noaa277

By:

Chuntova, Pavlina;
Chow, Frances;
Watchmaker, Payal B;
Galvez, Mildred;
Heimberger, Amy B;
Newell, Evan W;
Diaz, Aaron;
DePinho, Ronald A;
Li, Ming O;
Wherry, E John;
Mitchell, Duane;
Terabe, Masaki;
Wainwright, Derek A;
Berzofsky, Jay A;
Herold-Mende, Christel;
Heath, James R;
Lim, Michael;
Margolin, Kim A;
Chiocca, E Antonio;
Kasahara, Noriyuki

Publication type:

Article

Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 376, doi. 10.1093/neuonc/noaa249

By:

Vitanza, Nicholas A;
Biery, Matt C;
Myers, Carrie;
Ferguson, Eric;
Zheng, Ye;
Girard, Emily J;
Przystal, Justyna M;
Park, Giulia;
Noll, Alyssa;
Pakiam, Fiona;
Winter, Conrad A;
Morris, Shelli M;
Sarthy, Jay;
Cole, Bonnie L;
Leary, Sarah E S;
Crane, Courtney;
Lieberman, Nicole A P;
Mueller, Sabine;
Nazarian, Javad;
Gottardo, Raphael

Publication type:

Article

A broad perspective on evaluating bias in the neuro-oncology workplace.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 498, doi. 10.1093/neuonc/noaa286

By:

Kumthekar, Priya;
Dunbar, Erin M;
Peters, Katherine B;
Brastianos, Priscilla K;
Porter, Alyx B

Publication type:

Article

PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 387, doi. 10.1093/neuonc/noaa255

By:

Yi, Kaikai;
Zhan, Qi;
Wang, Qixue;
Tan, Yanli;
Fang, Chuan;
Wang, Yunfei;
Zhou, Junhu;
Yang, Chao;
Li, Yansheng;
Kang, Chunsheng

Publication type:

Article

A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 468, doi. 10.1093/neuonc/noaa240

By:

Gilbert, Mark R;
Yuan, Ying;
Wu, Jimin;
Mendoza, Tito;
Vera, Elizabeth;
Omuro, Antonio;
Lieberman, Frank;
Robins, H Ian;
Gerstner, Elizabeth R;
Wu, Jing;
Wen, Patrick Y;
Mikkelsen, Tom;
Aldape, Kenneth;
Armstrong, Terri S

Publication type:

Article

Intellectual changes after radiation for children with brain tumors: which brain structures are most important?

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 487, doi. 10.1093/neuonc/noaa217

By:

Tsang, Derek S;
Kim, Laurence;
Liu, Zhihui Amy;
Janzen, Laura;
Khandwala, Mohammad;
Bouffet, Eric;
Laperriere, Normand;
Dama, Hitesh;
Keilty, Dana;
Craig, Tim;
Ramaswamy, Vijay;
Hodgson, David C;
Mabbott, Donald

Publication type:

Article

TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 435, doi. 10.1093/neuonc/noaa198

By:

Nie, Er;
Jin, Xin;
Miao, Faan;
Yu, Tianfu;
Zhi, Tongle;
Shi, Zhumei;
Wang, Yingyi;
Zhang, Junxia;
Xie, Manyi;
You, Yongping

Publication type:

Article

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 422, doi. 10.1093/neuonc/noaa196

By:

Rossmeisl, John H;
Herpai, Denise;
Quigley, Mindy;
Cecere, Thomas E;
Robertson, John L;
D'Agostino, Ralph B;
Hinckley, Jonathan;
Tatter, Stephen B;
Dickinson, Peter J;
Debinski, Waldemar

Publication type:

Article

Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 478, doi. 10.1093/neuonc/noaa193

By:

Yang, Wen-Chi;
Chen, Ya-Fang;
Yang, Chi-Cheng;
Wu, Pei-Fang;
Chan, Hsing-Min;
Chen, Jenny Ling-Yu;
Chen, Guann-Yiing;
Cheng, Jason Chia-Hsien;
Kuo, Sung-Hsin;
Hsu, Feng-Ming

Publication type:

Article

Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 400, doi. 10.1093/neuonc/noaa188

By:

He, Yuyu;
Li, Jie;
Koga, Tomoyuki;
Ma, Jun;
Dhawan, Sanjay;
Suzuki, Yuta;
Furnari, Frank;
Prabhu, Varun V;
Allen, Joshua E;
Chen, Clark C

Publication type:

Article

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.

Published in:

Neuro-Oncology, 2021, v. 23, n. 3, p. 457, doi. 10.1093/neuonc/noaa168

By:

Jaeckle, Kurt A;
Ballman, Karla V;
van den Bent, Martin;
Giannini, Caterina;
Galanis, Evanthia;
Brown, Paul D;
Jenkins, Robert B;
Cairncross, J Gregory;
Wick, Wolfgang;
Weller, Michael;
Aldape, Kenneth D;
Dixon, Jesse G;
Anderson, S Keith;
Cerhan, Jane H;
Wefel, Jeffrey S;
Klein, Martin;
Grossman, Stuart A;
Schiff, David;
Raizer, Jeffrey J;
Dhermain, Frederick

Publication type:

Article